Slide 1: Global Leader in Investigative Analytics
GLOBAL LEADER IN INVESTIGATIVE ANALYTICS September 2024 Confidential Confidential and and proprietary proprietary information information of of Cognyte. Cognyte. 11
Slide 2: Disclaimers
DISCLAIMERS Forward Looking Statements This presentation contains "forward-looking statements," including statements regarding expectations, predictions, views, opportunities, plans, strategies, beliefs, and statements of similar effect relating to Cognyte Software Ltd. These forward-looking stateme
Slide 3: Cognyte Is Making the World Safer
COGNYTE IS MAKING THE WORLD SAFER By empowering organizations with our LAW NATIONAL unparalleled investigative analytics ENFORCEMENT INTELLIGENCE technology to identify threats, provide insights, and accelerate investigations and decision making NATIONAL SECURITY ~400 Customers Confidential and prop
Slide 4: Global Investigative Analytics Leader
GLOBAL INVESTIGATIVE 30 ~400 100+ 13 1,600+ ANALYTICS Years of Customers Countries Global Employees experience offices 3 years as an LEADER independent publicly traded company EMEA ~55% AMERICAS ~17% APAC ~28% *Regional Revenue % Confidential and proprietary information of Cognyte. All figures on th
Slide 5: A Platform with Growth Opportunities
A PLATFORM WITH GROWTH OPPORTUNITIES: VOLUME USE CASE FUNCTIONALITY Confidential and proprietary information of Cognyte. 5
Slide 6: Uniquely Designed for Our Customers' Data & Mission
Powerful data discovery capabilities UNIQUELY + Our AI-powered algorithms analyze numerous large and complex data sets to connect bits and DESIGNED FOR pieces of information and deliver insights to investigators OUR CUSTOMERS' + Generate previously unknown insights without needing to define the ques
Slide 7: Investigative Analytics Is More Crucial Than Ever
INVESTIGATIVE EXPONENTIAL EVER - ANALYTICS IS MORE DATA GROWTH INCREASING THREATS CRUCIAL THAN EVER IN VOLUMES AND DIVERSITY HIGHER TECHNOLOGY COMPLEXITY DISRUPTION Confidential and proprietary information of Cognyte. 7
Slide 8: Cutting Edge Technology
CUTTING EDGE TECHNOLOGY Strong competitive advantage and robust infrastructure for future innovation STATE OF THE ART ARCHITECTURE Flexible deployment & open interface ~300 Registered patents Cloud & on-prem PLUGGABLE MACHINE LEARNING ~800 R&D experts Enhances value to customers NO CODE DATA FUSION
Slide 9: AI – Accelerate Investigations' Speed, Accuracy and Success Rate
AI – ACCELERATE INVESTIGATIONS’ SPEED, ACCURACY AND SUCCESS RATE Leveraging the synergy of our AI research hub and deep domain expertise UNCOVERING MORE HIDDEN INSIGHTS FASTER AND MORE EFFICIENT EFFECTIVE PREDICTION MORE USE Uncovering connections and relations between entities, events Automated pro
Slide 10: Sanctions & Trade Compliance
Business is conducted in compliance with SANCTIONS & applicable economic and trade sanctions laws TRADE COMPLIANCE and regulations, such as those administered and enforced by: + State of Israel + U.S. Department of Treasury’s Office of Foreign Assets Control + U.S. Department of State + U.S. Departm
Slide 11: Strong Execution
Strong Execution Revenue Non-GAAP Gross Profit Improved Profitability Growth Growing Faster than Revenue Adjusted EBITDA Increasing $8.3 Growing & winning $83.7 $82.7 $84.4 $58.8 $60.2 customers $79.4 $57.8 $77.1 $55.7 $53.3 $5.0 Technology $4.6 $4.3 leadership $2.3 Leverage in Q2 FYE24 Q3 FYE24 Q4
Slide 12: Well Positioned for Future Growth
WELL POSITIONED FOR FUTURE GROWTH ADDRESSING LOYAL GLOBAL MANY USE CASES CUSTOMER BASE DIFFERENTIATED TECHNOLOGY DEEP DOMAIN OUR POWERED BY AI EXPERTISE PEOPLE Confidential and proprietary information of Cognyte. 12
Slide 13: Voice of Customers
LAW ENFORCEMENT IN THE US “We saved some lives today!” VOICE OF CUSTOMERS "Cutting edge solutions to meet National NATIONAL SECURITY IN LATIN AMERICA Security challenges within a service- minded approach." "The system allows for a considerable gain of time vs. the time it took to NATIONAL INTELLIGEN
Slide 14: Thank You
THANK YOU Confidential Confidential and and proprietary proprietary information information of of Cognyte. Cognyte. 14 14
Slide 15: Appendix
APPENDIX Confidential Confidential and and proprietary proprietary information information of of Cognyte. Cognyte. 15 15
Slide 16: Summary metrics
Summary metrics Confidential and proprietary information of Cognyte. 16
Slide 17: Revenue metrics
Revenue metrics Confidential and proprietary information of Cognyte. 17
Slide 18: Constant currency metrics
Constant currency metrics Confidential and proprietary information of Cognyte. 18
Slide 19: Gross profit
Gross profit Confidential and proprietary information of Cognyte. 19
Slide 20: Operating expenses
Operating expenses Confidential and proprietary information of Cognyte. 20
Slide 21: Operating and adjusted EBITDA margins
Operating and adjusted EBITDA margins Confidential and proprietary information of Cognyte. 21
Slide 22: Other income, tax and new income
Other income, tax and new income Confidential and proprietary information of Cognyte. 22
Slide 23: Tax and net income – FYE24 revised (footnote 3)
Tax and net income – FYE24 revised (footnote 3) Confidential and proprietary information of Cognyte. 23
Slide 24: EPS
EPS Confidential and proprietary information of Cognyte. 24
Slide 25: EPS – FYE24 Revised (footnote 3)
EPS – FYE24 Revised (footnote 3) Confidential and proprietary information of Cognyte. 25
Slide 26: Footnotes
Footnotes Confidential and proprietary information of Cognyte. 26
Slide 27: Supplemental information and non-GAAP measures
Supplemental information and non-GAAP measures Confidential and proprietary information of Cognyte. 27
Slide 28: Supplemental information and non-GAAP measures
Supplemental information and non-GAAP measures Confidential and proprietary information of Cognyte. 28
Slide 29: Supplemental information and non-GAAP measures
Supplemental information and non-GAAP measures Confidential and proprietary information of Cognyte. 29
Slide 30: Supplemental information and non-GAAP measures
Supplemental information and non-GAAP measures Confidential and proprietary information of Cognyte. 30